Functional genomic relationships in HIV-1 disease revealed by gene-expression profiling of primary human peripheral blood mononuclear cells.

BACKGROUND An assessment of biomarkers from an analysis of human peripheral blood mononuclear cell gene-expression profiles was made, to acquire an understanding of transcriptional changes associated with human immunodeficiency virus type 1 (HIV-1) infection in vivo. METHODS Supervised learning algorithms were used to create signature gene sets that could be used to distinguish seropositive from seronegative samples and delineate changes in disease status during the early stages of infection. Bioinformatic tools were used to classify persons and to functionally characterize groups of differentially expressed genes, to elucidate the impact of viral infection on host cell gene-expression patterns. RESULTS A 10-gene signature set that could be used to accurately determine the HIV-1 serostatus was identified. A 6-gene signature set was used to distinguish seropositive persons exhibiting differential changes in CD4(+) T cell counts, with 93% accuracy. Functional classification of differentially expressed genes in HIV-1 indicated a preponderance of down-regulated genes with functions related to the immune response and apoptosis. Hierarchical cluster analysis in persons whose CD4(+) T cell counts increased, compared with that in persons whose CD4(+) T cell counts decreased, was characterized by the down-regulation of genes associated with apoptosis, mitochondrial function, protein biosynthesis, and RNA binding. CONCLUSIONS Gene-expression profile analysis of a complex infectious virus, such as HIV-1, may be useful to elucidate the functional genomic relationships associated with viral infection.

[1]  R. Tibshirani,et al.  Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. , 2004, The New England journal of medicine.

[2]  R. Verhaak,et al.  Prognostically useful gene-expression profiles in acute myeloid leukemia. , 2004, The New England journal of medicine.

[3]  Bing Zhang,et al.  GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies , 2004, BMC Bioinformatics.

[4]  J. Carlis,et al.  Functional genomic analysis of the response of HIV-1-infected lymphatic tissue to antiretroviral therapy. , 2004, The Journal of infectious diseases.

[5]  T. Greenough,et al.  Down-Modulation of Mature Major Histocompatibility Complex Class II and Up-Regulation of Invariant Chain Cell Surface Expression Are Well-Conserved Functions of Human and Simian Immunodeficiency Virus nef Alleles , 2003, Journal of Virology.

[6]  R. Lempicki,et al.  Evaluation of gene expression measurements from commercial microarray platforms. , 2003, Nucleic acids research.

[7]  J. Sterne,et al.  Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies , 2003, The Lancet.

[8]  Purvesh Khatri,et al.  Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate , 2003, Nucleic Acids Res..

[9]  M. West,et al.  Gene expression predictors of breast cancer outcomes , 2003, The Lancet.

[10]  M. Nau,et al.  Patterns of gene expression in peripheral blood mononuclear cells of rhesus macaques infected with SIVmac251 and exhibiting differential rates of disease progression. , 2003, AIDS research and human retroviruses.

[11]  R. Morisset,et al.  Studies on the Production of IL-15 in HIV-Infected/AIDS Patients , 2003, Journal of Clinical Immunology.

[12]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[13]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[14]  D. Margolis,et al.  The regulation of HIV-1 gene expression: the emerging role of chromatin. , 2002, DNA and cell biology.

[15]  John W. Mellors,et al.  Predictive Value of Immunologic and Virologic Markers After Long or Short Duration of HIV‐1 Infection , 2002, Journal of acquired immune deficiency syndromes.

[16]  J. Downing,et al.  Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. , 2002, Cancer cell.

[17]  David Elashoff,et al.  Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study , 2002, The Lancet.

[18]  Julio S. G. Montaner,et al.  Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. , 2001, JAMA.

[19]  M. R. Caballero,et al.  Supervivencia y progresión de la enfermedad en 251 pacientes con infección por el VIH-1: Estudio del antígeno p24 y de la carga viral como marcadores pronóstico. Su valor a los 4 años de seguimiento , 2001 .

[20]  S. Hammer,et al.  Host Determinants in HIV Infection and Disease: Part 2: Genetic Factors and Implications for Antiretroviral Therapeutics* , 2001, Annals of Internal Medicine.

[21]  S. Hammer,et al.  Host Determinants in HIV Infection and Disease: Part 1: Cellular and Humoral Immune Responses* , 2001, Annals of Internal Medicine.

[22]  D. Dormont,et al.  Longitudinal analysis of CD8(+) T-cell phenotype and IL-7, IL-15 and IL-16 mRNA expression in different tissues during primary simian immunodeficiency virus infection. , 2001, Microbes and infection.

[23]  H. Kwon,et al.  Hostile takeovers: viral appropriation of the NF-kB pathway , 2001 .

[24]  C. Li,et al.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Corbeil,et al.  HIV induces lymphocyte apoptosis by a p53‐initiated, mitochondrial‐mediated mechanism , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  S. Hammer,et al.  Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team. , 2000, AIDS research and human retroviruses.

[27]  A Muñoz,et al.  A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects. , 1999, The Journal of infectious diseases.

[28]  J. Margolick,et al.  Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. , 1995, The New England journal of medicine.

[29]  D. Ho,et al.  Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. , 1995, The New England journal of medicine.

[30]  O. Bagasra,et al.  CD14 is involved in control of human immunodeficiency virus type 1 expression in latently infected cells by lipopolysaccharide. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[32]  T. Ito Nucleosome assembly and remodeling. , 2003, Current topics in microbiology and immunology.

[33]  M. Rubio Caballero,et al.  [Survival and disease progression in 251 patients with HIV-1 infection. Study of p24 antigen and viral burden as prognosis makers. Their value at 4 years of follow-up]. , 2001, Anales de medicina interna.

[34]  H. Kwon,et al.  Hostile takeovers: viral appropriation of the NF-kappaB pathway. , 2001, The Journal of clinical investigation.

[35]  N. Iizuka,et al.  MECHANISMS OF DISEASE Mechanisms of disease , 2022 .